header logo image


Page 21234..10..»

Archive for the ‘Stem Cell Tourism’ Category

Thalassemia Treatment Market projected to expand at a CAGR of 7.9% from 2018 to 2026 – The Daily Chronicle

Wednesday, September 30th, 2020

Transparency Market Research (TMR)has published a new report titled, Thalassemia Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20182026.According to the report, theglobal thalassemia treatment marketwas valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026. Increase in R&D investment by key players for developing new drugs for treating thalassemia and rise in demand for chelating therapy are anticipated to fuel the growth of the global market from 2018 to 2026. Asia Pacific and Middle East & Africa are expected to dominate the global market owing to increase in prevalence of thalassemia disorder and high adoption of chelation therapy & blood transfusion for treatment by doctors as well as patients. The market in Asia Pacific is projected to expand at the fastest CAGR during the forecast period. Growth of the market in the region is attributed to large base of private clinics and hospitals, rise in number of thalassemia population requiring chelation therapy services after spleen surgery, and surge in adoption of blood transfusion among patients. The thalassemia treatment market in Latin America is likely to expand at a moderate growth rate during the forecast period.

Request Brochure for Report https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=44462

Value Added Features in Thalassemia Treatments to Propel Global Market

The global thalassemia treatment market is projected to be driven by value added features offered by various thalassemia drug manufacturing companies in order to streamline the day to day work flow and increase revenue. The thalassemia treatment provides limited range of features and benefits ranging from patient pain heeling remedies to treatment procedures. For instance, very less number of people go for the much beneficial chelation therapy. These features help physicians and nurses to streamline the chelation therapy required for patients to maintain their daily workflow efficiently and effectively. Key players offering thalassemia treatment are coming up with value added features such as bone marrow transplantation, stem cell regeneration, gene editing methodologies, and effective modality features used for drug manufacturing along with creating a prominent candidate molecule for drugs. These features can reduce the overall operating cost and improve the overall effectiveness and efficiency of treatment practices. Companies are focusing on the development of combined drug therapy in their system to effectively integrate chelating therapy or other treatment procedure at an affordable cost. These value added features save time for physicians and help improve thalassemia patient survival performance.

Request for Analysis of COVID19 Impact on Thalassemia Treatment Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=44462

Chelation Therapy to be Highly Lucrative Segment

Traditionally, blood transfusion based on type of thalassemia treatment was the most commonly used procedure among thalassemia patients. This treatment type was associated with availability of donor and cost of treatment procedure. Moreover, chelation therapy based on thalassemia treatment are priced on perpetual license model and are expensive. Chelation therapy treatment enables patients to practice intensive therapy to treat acute iron overload leading to 90% recovery among thalassemia patients. These chelation therapy based treatments address specific challenges faced during the treatment procedure. The chelation therapy treatment facilitates benefits such as pain relief, and increase in motion of blood flow among patients.

Asia Pacific Presents Significant Opportunities

North America and Europe accounted for major share of the global thalassemia treatment market in 2017 and are likely to gain market shares by 2026. High rate of immigration from tropical regions, increasing health care budgets by governments, and government initiatives to promote thalassemia treatment technique contributed to the leading share of these regions. Asia Pacific is projected to be the most attractive market for thalassemia treatment, with highest attractiveness index. The market in Asia Pacific is expected to expand at a high CAGR of 9% during the forecast period due to large number of thalassemia patients opting for chelation therapy in developing countries such as India and China. Well-established health care facilities, medical tourism for treatment of thalassemia, and high adoption of blood transfusion safety technique in countries such as Turkey and GCC Countries are likely to drive the market in Middle East & Africa. The market in Latin America is poised to expand at a moderate growth rate during the forecast period.

Buy Thalassemia Treatment Market Report https://www.transparencymarketresearch.com/checkout.php?rep_id=44462&ltype=S

Trend of R&D among Leading Players to Increase Geographic Presence

The report also provides profiles of leading players operating in the global thalassemia treatment market. bluebird bio, Inc., Acceleron Pharma, Inc., Novartis AG, Celgene Corporation, and Shire plc (Takeda Pharmaceuticals) are the leading players operating in the global market. Companies operating in the thalassemia treatment market aim to increase geographic presence and research & development through strategic acquisitions and collaborations with leading players in respective domains and region. In December 2017, Shire plc committed to pay approximately US$ 1,409.9 Mn to contract vendors for administering and executing clinical trials. Other prominent players operating in the global thalassemia treatment include Incyte Corporation, Kiadis Pharma, Gamida Cell, Celgene Corporation, and Bellicum Pharmaceuticals.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

See the original post:
Thalassemia Treatment Market projected to expand at a CAGR of 7.9% from 2018 to 2026 - The Daily Chronicle

Read More...

Indian Biotechnology Market Market scrutinized in the new analysis – WhaTech

Tuesday, September 22nd, 2020

Indian Biotechnology Market Size, Share & Trends Analysis Report by Type (Healthcare, Crop Production and Agriculture, Industrial, Natural Resources & Environment, and Others) and Forecast 2020-2026

Indian biotechnology market is estimated to grow significantly at a CAGR of 8.1% during the forecast period. The increasing healthcare expenditure and increasing funding in cell-based research in the country are further supporting the biotechnology market in the country. The Government of India has taken some steps to promote cell harvesting techniques in the country and have set up numbers of stem cell banks throughout the country.

Report: http://www.omrglobal.com/requestogy-market

According to International Brand Equity Foundation (IBEF), the Indian healthcare market can increase three-fold to nearly $133.4 billion in 2022. The country is experiencing growth of around 22-25% in medical tourism. Various hospital chains such as Apollo Hospitals and Global Healthcare Enterprise are growing significantly in India due to a huge prevalence of cancer and related diseases. Private hospitals are expanding their business to provide a wide range of diagnostic tests and applications to a massive pool of cancer patients including foreign patients during medical tourism.

Browse for Full Report Description atwww.omrglobal.com/industrogy-market

The Indian biotechnology market is classified on the basis of type.

Based on type, the market is segmented into healthcare, crop production and agriculture, industrial, natural resources & environment, and others. The companies which are contributing to the growth of the Indian biotechnology market include Amgen Inc., Novo Nordisk A/S, CSL Ltd., Bristol-Myers Squibb Co., AstraZeneca PLC, Merck & Co., Inc., Johnson & Johnson Services Inc., and Pfizer Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market.

Market Segmentation

Indian Biotechnology Market by Type

Company Profiles

Report: http://www.omrglobal.com/report-ogy-market

This email address is being protected from spambots. You need JavaScript enabled to view it.

See the original post here:
Indian Biotechnology Market Market scrutinized in the new analysis - WhaTech

Read More...

Why Are There Only 10 Cell and Gene Therapies in… – Labiotech.eu

Tuesday, September 22nd, 2020

There is a lot of talk about how cell and gene therapy are going to change medicine, so why have only a few of them reached the market?

Over the last decade, only 14 advanced therapy medicinal products (ATMPs) that is, cell and gene therapies have received approval in Europe. With four withdrawals, only 10 of them still have a valid marketing authorization.

That is a stark contrast with the fact that there have been over 500 clinical trials using ATMPs in the EU since 2009. But the reality is that its a bit too soon to be expecting results many of these technologies are brand new and decades-old discoveries are only just reaching the market. For example, the development of Strimvelis, approved in 2016, took more than 20 years. The approval of Chondrocelect in 2009 took nine years since its developer, TiGenix, was founded.

Holoclar initially seemed like an exceptional case: research and development started around 1996 and the first clinical results were published just a year later. But one of its developers, Graziella Pellegrini, reported the product was under development for a total of 25 years. So those excited about CRISPR therapies, based on a gene-editing technology that was only developed in 2012, will still have to wait.

If the time scale wasnt daunting enough, research and development also burns cash quickly.A big chunk of the total money invested goes into meeting the quality, safety, and efficacy standards set by the regulatory authorities. This step seems to represent one of the biggest challenges for developers.

In fact, when regulations for ATMPs were first released in Europe, it appeared that authorities and researchers were on different wavelengths. In 2007, new European Union (EU) regulations on advanced therapies came in, which added more, very frustrating years to the development, said Pellegrini. It seemed that we had to start from scratch.

Thanks to frequent stakeholder consultations, these requirements are constantly being simplified, following the EMAs goal of fostering development and expanding patient access. But even with dynamic regulations, some products may only be authorized at thenational level and not for the whole continent.

For example, there is a dedicated pathway to exceptionally approve and commercialize ATMPs only locally as hospital exemptions. This status includes several limitations: this designation is only for non-routine products and those custom-made for individual patients, and importing or exporting them is illegal which can lead to the dangerous practice of stem cell tourism.

It seems complicated enough to reach the market with a cell or gene therapy, but the struggle isnt over at that point. The EMA can still withdraw a marketing application due to safety issues or if the company doesnt apply (and pay) for a renewal of the marketing authorization after five years.

That was the case of Glybera, the first gene therapy to receive approval in Europe. Its developers decided to not renew its market authorization after the therapys commercial failure in Europe and difficulties reaching the US market. With a very small target market and a price of one million euros, it was the most expensive treatment back in 2012, making it hard to convince governments and private insurance companies to pay for it.

In fact, only one person was treated with Glybera after its approval. Elisabeth Steinhagen-Thiessen, the doctor who prescribed it, had a lengthy fight with the German authorities and the insurance company to make them pay for the treatment. After the withdrawal, three doses left were given to patients for one euro each.

A big challenge for cell and gene therapies is that they often target conditions that affect a very small number of patients. Pharmaceutical companies are not much interested in unprofitable rare disease, commented Pellegrini.

In the case of Strimvelis, there are only about 14 people per year in Europe and 12 in the US diagnosed with its target disease, a rare form of genetic immune deficiency called ADA-SCID. The numbers are better for Holoclar, with around 1,000 people annually in Europe being eligible burn victims who have become blind but whose eyes have not been too extensively destroyed. Still,it is far short of a blockbuster.

There are exceptions, such as Imlygic, a therapy from Amgen approved in 2015 for the treatment of late-stage melanoma, with over 56,000 new cases across the EU each year.

Its fair to say that the majority of withdrawals have been made for business reasons, not safety issues. This highlights the fact that receiving EMA approval does not guarantee commercial viability the product can still be an economic failure.

Clearly, we have a lot of lessons to learn from past failure and success stories. As regulators and insurance companies become more familiar with cell and gene therapies, and developers avoid the mistakes made by others in the past, we can expect a future where cell and gene therapies become commonplace and no longer a futuristic hope.

Cover illustration by Elena Resko, images via Pharma Boardroom and the author. This article was published in April 2018 and has since been updated to reflect the latest EMA approvals.

Read the original here:
Why Are There Only 10 Cell and Gene Therapies in... - Labiotech.eu

Read More...

Colorado woman arrested for Assault in the Second Degree and Resisting Arrest – Maui Time

Sunday, September 13th, 2020

On September 11, 2020 at about 5:07 a.m., Tara Trunfio (24), from Colorado, was arrested for Assault in the Second Degree and Resisting Arrest.

Investigation reveals that on September 11, 2020 at about 3:46 a.m., Hana Patrol officers were assigned to the 4590 Hana Highway, regarding a female with a stab wound. It was alleged that Trunfio had earlier stabbed the victim while at the end of Ulaino Road.

Trunfio was located at the very end of Uluino Road. After advisement of her Constitutional Rights and being told she was under arrest, Trunfio physically and verbally resisted. A struggle ensued. Trunfio was taken into custody and transported to the Hana Police Station. She was assessed by Medic 6. Neither Trunfio nor Officers sustained or reported any injuries as a result of this incident.

Trunfio was later transported to the Wailuku Receiving Desk for processing.

On September 11, 2020 at about 11:01 a.m., Trunfio was formally charged for Assault in the Second Degree and Resisting Arrest. Her bail is set at $7,000. As of 12:15 p.m., she remains in Police Custody.

Press Release 9-120-20 Maui Police Department

comments

Read more:
Colorado woman arrested for Assault in the Second Degree and Resisting Arrest - Maui Time

Read More...

County seeking broadband need response – Mount Airy News

Sunday, September 13th, 2020

September 06, 2020

Doug McDaniel has spent much of his life sifting through decades worth of data online, scouring old newspapers and tracking down primary sources in hopes of documenting the athletic history of Mount Airy City Schools.

McDaniels meticulous research has connected Granite City student-athletes, coaches and fans of today with those of the past century. His work began primarily in football, but has since spread to sports across the board.

In all his trips down the rabbit hole, McDaniel has unearthed some of the most successful athletes in state history that also called Mount Airy home.

The 1973 graduate of Mount Airy High thought hed discovered the best athletes from the citys history, especially in football and basketball, by now. If someone told McDaniel there was someone he missed in his research, McDaniel would be skeptical to say the least.

Never in his life was McDaniel so elated to recently learn he was wrong.

As it turns out, a world class athlete named Ted McBride sat just a few pews away from McDaniel at Fellowship Missionary Baptist Church. The two knew each other for the better part of 50 years.

McDaniel just happened to run across an old article about McBride within the past year. McDaniel considered McBride a dear friend, but he had no clue McBride possessed such an incomparable resume. It included state championships, a few All-American selections and a pair of Olympic medals.

There was no question then that McBride deserved to be known as a true legend.

I think hes the best athlete that Surry County has ever known and maybe will know, McDaniel said.

McDaniel isnt the first to believe this, either. In a 1957 article from The Mount Airy News, author Joe Griffin said the following:

When one surveys the historical annals in search of who was probably the best athlete ever to emerge from the Granite City, he can hardly overlook the performances of a young deaf athlete by the name Ted McBride.

You name it, he did it

Ted Lee McBride was born Nov. 29, 1934, to parents Benson Boss and Kate McBride.

He grew up in a big, white frame house across from the old Flat Rock High School. According to McBrides widow, Eugenia, he attended school at Flat Rock until his mother realized he was not progressing.

As a result, his mother decided the best thing to do was to send McBride to the North Carolina School for the Deaf in Morganton.

She told me, That was the hardest thing I ever had to do, to leave my son; and I couldnt go back for two weeks, Eugenia McBride said, stressing how beneficial the move was to her sons life. Ted credits that to his success. He had good parents and good teachers that influenced him a whole lot.

McBride started attending the school in 1946. Because he wasnt fluent in sign language, McBride had a lot of catching up to do in school. As a result, he didnt enter high school until 1950, just a few months shy of 16.

School officials learned very quickly they had a star in the making. Griffins article stated that McBride was tall, fast and, most importantly, humble.

You name it, he did it, Eugenia said.

McBride morphed into an all-time great in football, basketball and track.

As a tight end and defensive end, McBride helped the school record three perfect seasons in 1951, 1953 and 1954. McBride earned All-American honors in three straight seasons from 1952-54. The school had an overall record of 22-2 during that three-season span.

The schools undefeated season in 1954 was good enough to rank them third in the nation. In addition to being named an All-American for a third time, McBride was named National Player of the Year by Silent Workers, a national magazine popular with the deaf population.

McBride also served as the schools basketball center during his high school years. He led the team in rebounding for most of his high school career and was named a member of the All-American Second Team by Silent Workers.

Track and Field was the latest of McBrides sporting endeavors, picking it up in 1953. It went on to be the sport in which he experienced the most success after high school.

While at the North Carolina School for the Deaf, McBride set numerous school records in hurdles as well as the pole vault. He led the team to a national championship and was named the top individual performer in the Asheville Relays the top state event in track.

McBride captured three state championships in the Western North Carolina High School Activities Association, which didnt merge with the N.C. High School Athletic Association until 1977.

Olympic Medalist

McBride aged out of high school sports in 1955. As he finished school, McBride played basketball in an industrial league in Morganton. He led the team to a 13-2 record and was named to the all-league team.

He later represented South Carolina in the National Deaf Tournament that year. Teams from across the country convened in Washington, D.C. McBride helped South Carolina finish second in the tournament.

Graduation came in 1956. He ended up staying in Morganton to work in the maintenance department.

The completion of high school did not mark the end of McBrides athletic career. In fact, he arguably made the biggest impact after school.

The United States was tasked with assembling a team for the 1957 Deaflympics in Milan, Italy.

From Griffins article: He was so well liked and respected that, when NCSD was given an invitation to enter an athlete for competition in the Deaf Olympics [sic], Ted was the unanimous choice.

Fundraisers in both Morganton and Mount Airy helped raise the $1,200 necessary to send McBride to Italy. He was set to compete in the 110-meter hurdles and 400-meter hurdles.

McBride stood tall at the international competition just as he had at every other level.

The 110-hurdles was McBrides specialty. He finished the race in 16.2 seconds to earn the gold medal. This was 0.8 seconds faster than the previous Deaflympics world record.

Competing in the 400-hurdles was new to McBride, as schools in the states only went up to 300 meters at the time. This was the first time hed competed in such a race competitively, and he still managed to grab a medal. He earned a bronze medal with a time of 56.7 seconds, just 0.2 seconds behind the silver medalist.

McBrides two medals helped Team USA win the overall track and field event. He was featured in publications such as The New York Times and in stories by the United Press.

His athletic career slowed following the Deaflympics. McBride earned an All-District award from the National Basketball Congress of America in 1959. He was later inducted into the North Carolina School for the Deaf Athletic Hall of Fame in 1979 and then the Southeast Athletic Association of the Deaf Hall of Fame in 2012.

Ted McBride is right up there with anybody as far as greatness goes, McDaniel said. I challenge anybody to have his credentials of athletic achievement. Not just countywide, not just statewide and not just nationwidebut internationally.

He was just Ted

Given McBrides incredible athletic past, its almost unfathomable to think most people never had a clue about it.

Eugenia McBride explained her husband was always humble and more interested in other peoples lives and stories. In fact, she said when they got married all of his medals and awards were in a shoebox in the trunk of his car.

He didnt brag about this, Eugenia McBride said. He was just Ted; a Mount Airy boy. If someone asked, he would tell you about it, but he never brought it up. Thats about the only way I know to describe it.

When he looked at you and he smiled I dont know how to explain it, McDaniel said. Its like a smile of caring and of love. Like saying, When Im looking at you, youre the most important person on earth.

Eugenia and Ted met through the Fellowship Missionary Baptist Church. A couple in the congregation had a daughter that was about to graduate from Ted McBrides old school and wanted to attend a church in Mount Airy that had an interpreter.

We had a missionary come to the church and God just called me, she said. I got a call to go to that alter at the end of the service to commit to learning sign language. I couldnt have done it without God.

The first teacher Eugenia McBride had left the church when she had been learning for a while, saying now was the time to immerse herself in sign language. So, she and a few women from church went to beg her future husband to teach them and he agreed.

Shortly after they began dating and eventually married in 1970.

I tell everybody I married the teacher, Eugenia said.

Together, the two had a daughter, Rebecca, that is now married to Brad Calloway. Rebecca and Brad have two children in college: Hayden and Haley.

Ted McBride went on to work at Pike Electric and was well respected as a master electrician, McDaniel said. He attended church every week he was able and always cared for his friends and family.

Eugenia McBride said that being deaf did not bother Ted, and that he didnt see it as a handicap. Rather, it was just the way life was. Whether in athletics or when raising a family, McBride worked hard and never took shortcuts. It he was going to do something, it was going to get done right, Eugenia McBride said.

I get a little emotional about Ted McBride because he was such a dear friend of ours, McDaniel said. He would kind of get you started about what youre doing and never wanted to talk about himself. He just kind of deferred everything away from him. To be more like Ted McBride is what we should all strive for.

Up here we didnt even know about his past, and down there in Morganton hes a legend. He needs to be a legend up here, and he needs to be talked about.

Read more here:
County seeking broadband need response - Mount Airy News

Read More...

ProgenCell – Stem Cell Therapies announces new facilities – PR Web

Friday, August 28th, 2020

Our patients will have access to even more services and extraordinary specialists available at the medical tourism complex, in a convenient and strategic location.

SAN DIEGO (PRWEB) August 25, 2020

ProgenCell - Stem Cell Therapies is announcing the opening of its brand new Stem Cell Treatment Center to give international and local patients a more comprehensive medical treatment in a luxury and stress free environment. With this announcement, ProgenCell establishes its leadership in the field of regenerative medicine and medical tourism. ProgenCells New Clinic is part of the one of a kind all-in-house medical tourism complex: NewCity Medical Plaza.

A great deal of planning went into making this stem cell treatment right for the wide range of medical conditions we deal with, said Dr Jorge Gavino, president of ProgenCell Scientific Committee. Our patients will have access to even more services and extraordinary specialists available at the medical tourism complex, in a convenient and strategic location. Im excited to welcome patients at this new facility.

It has been a long journey. Time had given lot of experience since 2008, when the clinic was found, said Elias Bemaras, CEO. Stem cell therapy has evolved, has improved in many ways, getting better results, learning from long term treated patients. We understand the need for a new facility, more convenient for patients with equipment renovation, better distribution, and a better location. Although a high investment is required, we believe it is worth it because our patients will receive better service, easier logistics, more time with the doctor, better follow up, and that translates to 360 degrees patient satisfaction.

With this new facility, ProgenCell establishes its commitment to offer the most advanced technology in modern and comfortable facilities and in a fully licensed, government regulated and certified facility, overseen by an independent ethics and scientific committee.

About ProgenCell - Stem Cell TherapiesProgenCell - Stem Cell Therapies is a leading stem cell treatmentcenter that offers individualized stem cell therapies for patients with chronic-degenerative diseases with more than 10 years of experience. ProgenCell also provides assistance with lodging, traveling and logistics to provide a comprehensive and safe medical tourism experience.ProgenCell is now part of the Health System of NewCity Medical Plaza, a modern and innovative Medical Tourism Center in Tijuana, Mexico. NewCity Medical Plaza is a 30-story tower, with doctors offices, hospital, medical lab, imaging center, commercial plaza, gastronomic center and a 140-room five star hotel.

To learn more about ProgenCell new facilities or scheduling inquiries contact ProgenCell directly at 1 888 443 6235 or email info@progencell.com

Share article on social media or email:

Go here to see the original:
ProgenCell - Stem Cell Therapies announces new facilities - PR Web

Read More...

Autologous Cell Therapy Market Along With Covid-19 Impact Analysis and Business Opportunities Outlook 2027 – Scientect

Tuesday, August 25th, 2020

Transparency Market Research (TMR)has published a new report titled, Autologous cell therapy Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20192027. According to the report, the globalautologous cell therapy marketwas valued atUS$ 7.5 Bnin2018and is projected to expand at a CAGR of18.1%from2019to2027.

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) :https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715

Overview

Rise in Prevalence of Neurological Disorders & Cancer and Others to Drive Market

REQUEST FOR COVID19 IMPACT ANALYSIS https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=715

Bone Marrow Segment to Dominate Market

Neurology Segment to be Highly Lucrative Segment

Hospitals Segment to be Highly Lucrative Segment

North America to Dominate Global Market

Competitive Landscape

Read our Case study at :https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

The global autologous cell therapy market has been segmented as follows:

More Trending Reports by Transparency Market Research 1.https://www.prnewswire.com/news-releases/bronchitis-treatment-market-to-reach-us-4-7-bn-by-2026high-prevalence-of-air-pollution-drives-growth-transparency-market-research-301003635.html

2.https://www.biospace.com/article/personal-mobility-devices-market-rising-in-various-regions-owing-to-increased-geriatric-population/

See the original post here:
Autologous Cell Therapy Market Along With Covid-19 Impact Analysis and Business Opportunities Outlook 2027 - Scientect

Read More...

Candle Lit Tour and New Outdoor Exhibits Coming to the Baldwin Home Museum – Maui Time

Saturday, August 22nd, 2020

The new sports exhibit shows off some of Lahainas Pioneer Mill era sports teams.

Come take a step back into Lahainas past as Candle Lit Tours return to the Baldwin Home Museum starting Friday, Sept. 4 from 5 8 pm, alongside a new, free Pioneer Mill era sports exhibit. The tours and exhibits will be held weekly in conjunction with Friday Night is Art Night.

The Candle Lit Tour explores the fully furnished 19thcentury Baldwin Home which will be illuminated by dozens of candles. Tours are $5 per person with children 12 and under free. Each 20 minute tour is limited to 5 people. Signups will be taken on site. Docents will walk each group through the home, and once they are back outside, questions will be taken. The docents of the popular tour are excited for a return to educating the public, and invite the community to take a step back into time.

A free exhibit featuring photographs of a variety of sports teams from the Pioneer Mill era will be on display on the Baldwin Home lawn. The exhibit shows off the many memories of youth, club and community sports from the 1930s to the 1970s.

The public is invited to stroll through Historic Lahaina Town for the festive Friday Night is Art Night. Visitwww.LahainaRestoration.org for a list of participating galleries.

In conformance with Maui County regulations, masks must be worn on the candle lit tour and while looking at the outdoor exhibits. Single use masks, and hand sanitizer will be available on site and social distancing will be enforced. Please be conscious of the safety and comfort of yourself and others when attending.

Contactevents@lahainarestoration.orgfor more information

Press Release and Image courtesy Lahaina Restoration Foundation

comments

Read the original post:
Candle Lit Tour and New Outdoor Exhibits Coming to the Baldwin Home Museum - Maui Time

Read More...

Deals Under the Radar: These Are the Israeli Tech Companies Already Operating in the UAE – Algemeiner

Saturday, August 22nd, 2020

A general view of ADNOC headquarters in Abu Dhabi, United Arab Emirates May 29, 2019. Photo: REUTERS/Christopher Pike/File Photo.

CTech Im very active on LinkedIn, I have tens of thousands of contacts and I receive around 10 new requests a day, but something weird happened last Friday. I was swamped with new follower requests. I thought my account was hacked, but when I began looking through the names and the accounts analytics I saw that they were all businessmen and senior executives from insurance companies in the United Arab Emirates, Yariv Yanay, Director of Business Development and Innovation at Hachshara Insurance Company, told Calcalist.

Yanay is one of the founders of the go Digital Insurance application developed by Hachshara for digital car insurance. I approved all the requests and already set Zoom meetings with them. They ask serious questions that show that they know what they need from us. A representative from a big insurance company there asked me a very specific question about one of our developments in UBI (usage-based insurance) while someone else was interested in learning about dealing with claims digitally, and another inquired if the product suits a B2C market. It was apparent that they had done their homework.

Israel has become an insurtech powerhouse in recent years, even though local consumers arent aware of the services being offered by many of the companies.

Right now, I feel like they are checking us out because they have heard that Israel is an insurtech superpower, noted Yanay. The potential isnt just in the possible sale of products to the UAE, but that this can also lay the infrastructure for entering the rest of the Arab world and places like Jordan and Egypt. I take part in many international conferences and until now it was very obvious we were outcasts.

August 22, 2020 10:39 am

By complete coincidence, Yarivs brother, the CEO and President of biomed company Pluristem, announced on Monday that the regenerative medicine company developing a platform of novel biological therapeutic products has signed a non-binding Memorandum of Understanding (MOU) with the UAE-based Abu Dhabi Stem Cells Center (ADSCC), a specialist healthcare center focused on cell therapy and regenerative medicine.

Alongside insurtech and biomedicine, the fintech sector has also generated plenty of interest in the UAE. The Israeli fintech sector, which includes 530 startups, attracted record funding of $2 billion during 2019. This looks like a match made in heaven, said Shmulik Ben-Tovim, president of the Fintech Community of Israel. While Israel is regarded as a tech powerhouse, but an undeveloped financial center, in Dubai there is the exact opposite situation. Israeli fintech companies will literally be entering a desert.

Israel nowadays is mainly known in the Gulf states for its aesthetics medical innovation as Dubai and Abu Dhabi have a young and rich population, noted Adi Nov, deputy manager at ICIC-Israel Credit Insurance Company. Another strong sector is agtech, specifically irrigation technology. There is also business in the plastic industry and some fashion, mainly swimwear and underwear.

According to Paris-based insurance company Euler Hermes, which holds shares in ICIC, Israels areas of expertise are similar to those of the US which is the third-largest exporter to the UAE after China and India and is responsible for 10% of the imports in the weapons and tech sectors.

Israels tech companies werent waiting around for Donald Trumps announcement that Israel and the UAE had agreed to normalize ties, with many companies doing business in the region for several years. Most of them do so via a local distributor, but companies like Cybereason, which is based out of the US, have offices in the UAE.

The UAE is a very special and significant market, said Shai Horovitz, Chief Revenue Officer at Cybereason. The leading investor in Cybereason is the Vision Fund, with half of its $100 billion under management coming in from the Persian Gulf and Saudi Arabia. As a result, the Israeli cyber company has relationships in the region dating back many years.

There are several Israeli cybersecurity companies currently operating successfully in the UAE, including Check Point, which states on its website that it has representation in Dubai; CyberArk, which works with a local distributor; and IntSights, which has significant sales in the region.

There is a clear need for cybersecurity products due to geopolitical reasons. The Emirates encounter the same threats that our western clients are facing. The same actors that threaten large financial institutions and government agencies in Europe and the US are also acting against the UAEs interests, explained Horovitz.

Guy Nizan, co-founder and CEO of IntSights, said that Israeli tech is received very well in the region. It is an advantage because the client recognizes Israeli tech as a brand. Moreover, they understand the importance of security and are willing to invest a lot in the sector.

And it isnt just Israeli cybersecurity that is prospering in Dubai. There are several other Israeli tech companies that have made a name for themselves, including Cato Networks, whose core product is a cloud service and operates a server farm in Dubai. Israeli giant Monday.com has also become well known in the UAE over the past three years and is partnering with several companies in the region.

We have over 700 clients in the Persian Gulf and over the last year the company increased its sales in the region by 300% and is planning on reaching sales of $5 million by the end of 2021, said Barak Zigdon, partnerships and global resellers manager at Monday.com. Software company JFron is also selling to clients in the UAE.

One sector with great potential in the area is agtech, mainly due to the dry climate in both Israel and the UAE.

We have been talking to different actors in the UAE about promoting desert agriculture projects, said Or Haviv, partner and head of ventures at Arieli Capital. There is no done deal, but we were already discussing it prior to last weeks announcement. The UAE wants to learn how to do agriculture in the desert and gain produce which is at the level of that grown in Israel. There is a plan to send a delegation from the UAE to Israel so that they can undergo training at Ramat Negev.

Alan Feld, co-founder and managing partner at Vintage Investment Partners, believes that the UAE is open to investing in Israeli tech in addition to purchasing its products. I believe that we will very soon see investments in VCs and Israeli companies. They have a VC industry and they also want us to invest in their companies.

The entire region is a desert and in the middle of it they built an amazing airport and one of the best tourism systems Ive seen, added Feld, who was in the UAE in February. They want to diversify their sources of income and not be so dependent on the price of oil. They see themselves as a regional technology center and Israel is a good source of technology for them.

Boaz Dinte, managing general partner at Qumra Capital, added: Over the past two years we have received more and more approaches from people in the region who are interested in investing in Israeli funds and Israel in general. From a personal standpoint, I was a little wary as I didnt know what the consequences would be for the fund if we received money from the Gulf. I was uncertain what it would mean and if it would put constraints on the fund, but now it has clearly become legitimate.

Read the original:
Deals Under the Radar: These Are the Israeli Tech Companies Already Operating in the UAE - Algemeiner

Read More...

Cell Separation Technology Market is Anticipated to Expand at a CAGR of ~ 12% during 2019 2027 – Press Release – Digital Journal

Saturday, July 11th, 2020

Cell Separation Technology Market is boosted by advancements in technology, increase in the geriatric population, surge in investments in research & development.

Transparency Market Research (TMR) has published a new report on the global cell separation technology market for the forecast period of 20192027. According to the report, the global cell separation technology market was valued at ~ US$ 5 Bn in 2018, and is projected to expand at a double-digit CAGR during the forecast period.

Overview

Cell separation, also known as cell sorting or cell isolation, is the process of removing cells from biological samples such as tissue or whole blood. Cell separation is a powerful technology that assists biological research. Rising incidences of chronic illnesses across the globe are likely to boost the development of regenerative medicines or tissue engineering, which further boosts the adoption of cell separation technologies by researchers.

Expansion of the global cell separation technology market is attributed to an increase in technological advancements and surge in investments in research & development, such as stem cell research and cancer research. The rising geriatric population is another factor boosting the need for cell separation technologies Moreover, the geriatric population, globally, is more prone to long-term neurological and other chronic illnesses, which, in turn, is driving research to develop treatment for chronic illnesses. Furthermore, increase in the awareness about innovative technologies, such as microfluidics, fluorescent-activated cells sorting, and magnetic activated cells sorting is expected to propel the global cell separation technology market.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1925

North America dominated the global cell separation technology market in 2018, and the trend is anticipated to continue during the forecast period. This is attributed to technological advancements in offering cell separation solutions, presence of key players, and increased initiatives by governments for advancing the cell separation process. However, insufficient funding for the development of cell separation technologies is likely to hamper the global cell separation technology market during the forecast period. Asia Pacific is expected to be a highly lucrative market for cell separation technology during the forecast period, owing to improving healthcare infrastructure along with rising investments in research & development in the region.

Rising Incidences of Chronic Diseases, Worldwide, Boosting the Demand for Cell Therapy

Incidences of chronic diseases such as diabetes, obesity, arthritis, cardiac diseases, and cancer are increasing due to sedentary lifestyles, aging population, and increased alcohol consumption and cigarette smoking. According to the World Health Organization (WHO), by 2020, the mortality rate from chronic diseases is expected to reach 73%, and in developing counties, 70% deaths are estimated to be caused by chronic diseases. Southeast Asia, Eastern Mediterranean, and Africa are expected to be greatly affected by chronic diseases. Thus, the increasing burden of chronic diseases around the world is fuelling the demand for cellular therapies to treat chronic diseases. This, in turn, is driving focus and investments on research to develop effective treatments. Thus, increase in cellular research activities is boosting the global cell separation technology market.

Increase in Geriatric Population Boosting the Demand for Surgeries

The geriatric population is likely to suffer from chronic diseases such as cancer and neurological disorders more than the younger population. Moreover, the geriatric population is increasing at a rapid pace as compared to that of the younger population. Increase in the geriatric population aged above 65 years is projected to drive the incidences of Alzheimers, dementia, cancer, and immune diseases, which, in turn, is anticipated to boost the need for corrective treatment of these disorders. This is estimated to further drive the demand for clinical trials and research that require cell separation products. These factors are likely to boost the global cell separation technology market.

According to the United Nations, the geriatric population aged above 60 is expected to double by 2050 and triple by 2100, an increase from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion by 2100.

Request for Analysis of COVID19 Impact on Cell Separation Technology Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1925

Productive Partnerships in Microfluidics Likely to Boost the Cell Separation Technology Market

Technological advancements are prompting companies to innovate in microfluidics cell separation technology. Strategic partnerships and collaborations is an ongoing trend, which is boosting the innovation and development of microfluidics-based products. Governments and stakeholders look upon the potential in single cell separation technology and its analysis, which drives them to invest in the development of microfluidics. Companies are striving to build a platform by utilizing their expertise and experience to further offer enhanced solutions to end users.

Stem Cell Research to Account for a Prominent Share

Stem cell is a prominent cell therapy utilized in the development of regenerative medicine, which is employed in the replacement of tissues or organs, rather than treating them. Thus, stem cell accounted for a prominent share of the global market. The geriatric population is likely to increase at a rapid pace as compared to the adult population, by 2030, which is likely to attract the use of stem cell therapy for treatment. Stem cells require considerably higher number of clinical trials, which is likely to drive the demand for cell separation technology, globally. Rising stem cell research is likely to attract government and private funding, which, in turn, is estimated to offer significant opportunity for stem cell therapies.

Biotechnology & Pharmaceuticals Companies to Dominate the Market

The number of biotechnology companies operating across the globe is rising, especially in developing countries. Pharmaceutical companies are likely to use cells separation techniques to develop drugs and continue contributing through innovation. Growing research in stem cell has prompted companies to own large separate units to boost the same. Thus, advancements in developing drugs and treatments, such as CAR-T through cell separation technologies, are likely to drive the segment.

As per research, 449 public biotech companies operate in the U.S., which is expected to boost the biotechnology & pharmaceutical companies segment. In developing countries such as China, China Food and Drug Administration (CFDA) reforms pave the way for innovation to further boost biotechnology & pharmaceutical companies in the country.

Buy Cell Separation Technology Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=1925&ltype=S

Global Cell Separation Technology Market: Prominent Regions

North America to Dominate Global Market, While Asia Pacific to Offer Significant Opportunity

In terms of region, the global cell separation technology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global market in 2018, followed by Europe. North America accounted for a major share of the global cell separation technology market in 2018, owing to the development of cell separation advanced technologies, well-defined regulatory framework, and initiatives by governments in the region to further encourage the research industry. The U.S. is a major investor in stem cell research, which accelerates the development of regenerative medicines for the treatment of various long-term illnesses.

The cell separation technology market in Asia Pacific is projected to expand at a high CAGR from 2019 to 2027. This can be attributed to an increase in healthcare expenditure and large patient population, especially in countries such as India and China. Rising medical tourism in the region and technological advancements are likely to drive the cell separation technology market in the region.

Launching Innovative Products, and Acquisitions & Collaborations by Key Players Driving Global Cell Separation Technology Market

The global cell separation technology market is highly competitive in terms of number of players. Key players operating in the global cell separation technology market include Akadeum Life Sciences, STEMCELL Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Miltenyi Biotech, 10X Genomics, Thermo Fisher Scientific, Inc., Zeiss, GE Healthcare Life Sciences, PerkinElmer, Inc., and QIAGEN.

These players have adopted various strategies such as expanding their product portfolios by launching new cell separation kits and devices, and participation in acquisitions, establishing strong distribution networks. Companies are expanding their geographic presence in order sustain in the global cell separation technology market. For instance, in May 2019, Akadeum Life Sciences launched seven new microbubble-based products at a conference. In July 2017, BD received the U.S. FDAs clearance for its BD FACS Lyric flow cytometer system, which is used in the diagnosis of immunological disorders.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media ContactCompany Name: Transparency Market ResearchContact Person: Mr. Rohit BhiseyEmail: Send EmailPhone: 5186181030Address:90 Sate Street, Suite 700 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.transparencymarketresearch.com/

More:
Cell Separation Technology Market is Anticipated to Expand at a CAGR of ~ 12% during 2019 2027 - Press Release - Digital Journal

Read More...

Impact Analysis of COVID-19 on Stem Cells Market Study 2018-2028 Segmented On The Basis of Product Type, Geographical Analysis, Future Forecast,…

Saturday, July 11th, 2020

The global stem cells market is driven by various factors which include increasing prevalence and incidence rate of cancer and cancer-related diseases. Rising research and development programs, increasing awareness related to regenerative treatment, increasing the use of biomarkers and growth in biopsy market are also driving the market. The high prevalence of cancer in children is also a key driving factor for stem cell study. The number of stem cell banks has increased exponentially.

The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).

The number of hospitals and research centers in developed countries is capable of storing stem cells. Even in countries such as China and India, the growing awareness amongst the professionals and masses is the key driver for the market. India, China, and other emerging nations are also offering stem cell therapies and services and lower cost which is leading to the emergence of medical tourism in the stem cells market.

Request To Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10233576

The market is segmented on the basis of product type, applications, and technology. The product types consist of adult stem cells, human embryonic stem cells market, induced pluripotent stem cells market, and very small embryonic-like cells market. Applications include regenerative medicines market which is further segmented as cancer regenerative medicines market, orthopedics regenerative medicines market, hematological regenerative medicines market, neurological regenerative medicines market, cardiovascular regenerative medicines market, regenerative medicines market, injuries regenerative medicines market and others regenerative medicines market.

Drug discovery is also a major application. Stem cells market by technology includes bone marrow harvest, apheresis, umbilical blood cord, therapeutic cloning, in vitro fertilization, isolation, cell culture, cryopreservation, and expansion and subculture.

Request To Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10233576

Geographically, the market is a segment as North America, Europe, Asia Pacific and the rest of the world. North America has the highest market share followed by Europe and the Asia Pacific. The Asia Pacific is expected to report the highest growth rate for the forecasted period. Key companies in the market include STEMCELL technologies, Millipore, Corning, BioTime Inc, Advanced Cell technology Inc, Cellular engineering technologies and other major companies.

How does the report examine the growth drivers and restraints of the Stem Cells Market?

Request To Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10233576

Company profiles

1. STEMCELL technologies2. Millipore3. Corning4. BioTime Inc5. Advanced Cell Technology Inc6. Cellular engineering technologies7. Cellartis AB8. Angel Biotechnology9. Bioheart Inc10. Cellgene corporation11. Brainstorm cell therapeutics12. Osiris therapeutics13. BD biosciences14. Lonza15. ATCC16. Allcells17. Miltenyi biotec GmBH18. QIAGEN19. Novocell20. Stemgent21. Sigma Aldrich22. Invitrogen23. Nunc24. Peprotec25. R&D systems26. Cellular dynamics international27. ChanTest corporation28. Wiicell research institute29. Hybrid Organ GmBH30. BIOE31. Aastrom Biosciences32. California Stem Cells33. International Stem Cell Corporation34. NeoStem35. NeuralStem36. Medistem37. Apceth38. Cardio3 BioSciences39. TiGenix

This Research Report covers

1. Historical data2. Revenue forecasts, growth rates and CAGR up to 20283. Industry Analysis4. Competitive Analysis5. Key geographic growth data

Request for Complete Report:https://www.kennethresearch.com/sample-request-10233576

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations, and organizations with the aim of helping them to take prominent decisions. Our research library comprises more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both the macro level as well as micro-level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides a significant analysis of various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keeps a track of the international and domestic market for any economic changes impacting the products demand, growth, and opportunities for new and existing players.

Updated Research Report Available @Kenneth Research with impact analysis of COVID-19

In-Office Dental Bleaching Kits MarketInnohep MarketInlet and Exhaust Manifold MarketInjectable Anticoagulants MarketInhalation Generic Drug MarketInfusion System Market

View post:
Impact Analysis of COVID-19 on Stem Cells Market Study 2018-2028 Segmented On The Basis of Product Type, Geographical Analysis, Future Forecast,...

Read More...

Facial Injectable Market Growth Analysis, Size Projection, Key Insights, COVID-19 Impact Analysis and Future Trends By 2025 – Cole of Duty

Friday, July 10th, 2020

Global Facial Injectable Market Share, Growth and Trends Analysis by Type (Botulinum Toxin, Hyaluronic Acid, Polymers and Particles and Collagen), Application (Facial Line Correction Treatment, Face Lift and Lip Treatments), End User (Hospitals, Specialty Clinics and Spa & Beauty Clinic) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) Forecast till 2025

Anti-ageing, face rejuvenation and cosmetic treatments have changed the rules of engagement and reinvention. Today, its possible to change the basic elements of yourself to fulfil the basic desire of humans to be young.

Thefacial injectable marketis been driven by numerous factors. However rising proportion and absolute numbers of older people led by baby boomers generation with good incomes are the critical driving factor for the global facial injectable market. According to the World Health Organization estimates between 2015 and 2050, the proportion of the worlds population over 60 years will double from 12% to 22% which will be a positive development for the market.

Another critical driver and the motive behind the market is the primal desire to remain young. The extension of life has been a primal desire of humanity and a mainstay motif in the history of scientific pursuits and ideas throughout history, from the Egyptian Smith medical papyrus, Ayurveda practitioners, alchemists, etc. This primal desire for youth has driven the market for anti-ageing drugs since time immemorial.

Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/1527

The growing influence of lifestyle, fashion and film industry have led to rising demand of medications to slow the ageing and its signs. Health and youth wellness have become a status symbol and youthful appearance is penetrating peoples life and there is increasing consumerization of youth. The growth of media such as television and lifestyle magazines have led to a craze for youthful appearance.

Other driving factors are primal desire of humans to remain young, influence of lifestyle industry and rising awareness about wellbeing, high levels of disposable incomes etc. The market restraints are skepticism and concerns of safety regarding the unrestricted use of anti-ageing drugs without greater and clearer experimental validation. Ambiguity of the definition of anti-ageing drugs is also a cause of concern. For example, numerous cosmetics have been included or claimed to have anti-aging effects and have been termed as Cosmeceuticals. Cosmeceutical is defined by the cosmetic industry as cosmetic products that have medicinal or drug like effects which is not supported by the U.S. Food and Drug Administration (FDA) or the Food, Drug and Cosmetic Act.

The facial injectable market is a technological oriented market having a high research and development potential due to advancement in technologies and cellular understanding which are keys to unravel the exact mechanism of ageing. Gene therapy, stem cell technology and targeted delivery of nutrients using biotechnology are expected to open the gates for anti-ageing drugs. The development of biomarkers for physiochemical modifications in the body such as alteration of concentration of an enzyme or hormone provides another exiting avenue for the future market. For example, levels of homocysteine has been proposed as a marker of age related changes in the body so as to compensate the change by drugs.

From a market perspective the facial injectable market is ripe with mergers, acquisitions and partnerships. For example, in 2017, cosmetic giant LOral acquired skincare brands such as CeraVe, AcneFree and Ambi from Valeant Pharmaceuticals at ~ $1.25 billion. In 2016, Johnson & Johnson acquired Vogue International LLC, for greater than $3 billion to strengthen its consumer segment. Thus, partnerships seem to be a good strategy to curtail the developmental cost of any new facial injectable drug. Acquisition of other companies also leads to expansion of product lines which improves market penetration and exposure.

The global market for facial injectable is expected to reach USD 9.04 billion by the end of the forecasted period 2023 and is expected to grow at a CAGR of 13.2%

Global facial injectable market is segment by types and applications. Based on types the market is sub-segmented as botulinum toxin, hyaluronic acid, polymers & particles, and collagen. On the basis of application, the market is sub-segmented into facial line correction treatment, face-lift, lip treatments and others.

The key players in his market are Allergan, Galderma, Integra Lifesciences, Merz Pharma, Sanofi, SciVision Biotech Inc, Sinclair. Suneva Medical and Valeant Pharmaceuticals.

Regional outlook for the facial injectable market

The facial injectable market is dominated by North America. The U.S. is the prime mover of the facial injectable market. However, it has to be noted that Latin America despite its lower per capita income has a disproportionate share of the market. It is estimated that Latin America will be the fastest in the future. As of the present the European regions is expected to be the second largest market globally, with countries like Germany, UK and France playing a prominent role in the market. Germany accounts for both the largest and the fastest growing nation in the European region facial injectable market, followed by France.

Asia Pacific market is expected to be the fastest future growing market during the forecast period 2016-2023. The Asia Pacific region will be led by countries such as China and India. However the greatest hindering reasons for the Asia pacific region market is the poor per capita income and the high cost of treatment. Nations such as Thailand etc. have a disproportionate share of Asia Pacific market considering their low income as compared to the U.S. The market of these nations is influenced to a considerable degree by the tourism and fashion industry. Advertisement and greater exposure seems to be the best strategy to be a market leader along with product development. The return on investment for advertisement and publicity is very high for the cosmetic surgery market.

There has been a definite shift of the cosmetic surgery market from the developed regions to the developing ones particularly Latin America and Asia Pacific countries such as Thailand. The market represents a clustered outlook with urban metropolitan cities especially with adjoining tourism and fashion industry having an extreme lead over the rural areas. Large tourism clusters such as Miami, Bangkok, Bali etc. have a disproportionate share of the market due to the large volume of cosmetic surgeries.

The porn industry also is affecting the market and it has been seen that the rise of cosmetic surgeries has a linear relationship with the quality and bandwidth of the internet. Thus cities such as Los Angeles, Las Vegas etc. are the leading clusters of cosmetic surgery market.

Browse Complete Research Report with COVID-19 Impact Analysis at:https://www.marketresearchfuture.com/reports/facial-injectable-market-1527

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [emailprotected]

Follow this link:
Facial Injectable Market Growth Analysis, Size Projection, Key Insights, COVID-19 Impact Analysis and Future Trends By 2025 - Cole of Duty

Read More...

Are Hispanics Victims of Inequities in COVID-19 Epidemic? – Bacon’s Rebellion

Friday, July 10th, 2020

Jennifer Carroll Foy

by James A. Bacon

Hispanics make up 9% of Virginias population but 43% of the states COVID-19 cases. So, it seems a not-unreasonable thing for Del. Jennifer Carroll Foy, D-Prince William, a candidate for governor, to call upon Governor Ralph Northam to increase funding for outreach over Spanish-language media to build public awareness about the virus.

But then in her letter to the governor, she said some things that arent so reasonable: The rates of infection are alarming, and magnify the inequities that are staring us in the face. They stem from longstanding and systemic factors, such as disparate access to information, testing, and treatment.

Here we go again: inequities, systemic factors and disparate access. It is so widely assumed that Virginia is a hellhole of inequity and prejudice that no one even tries to prove statements like Foys. (Shes hardly alone in making them.) The allegations are accepted without question.

Lets take a look at the numbers. The first thing to note is that the Hispanic population in Virginia has surged over the past two decades from 239,000 in 2000 to 619,000 this year. Most of this increase was driven by immigration into the state. It is safe to assume that a large percentage come from poor countries in search of economic opportunity. With little education, most immigrants sought employment in occupations requiring manual skills. As a consequence, to quote Virginia Public Media, 85% of Latinos cant work at home. They must leave their houses to go to work and get paid, which makes them more likely to be exposed to COVID-19.

After accepting thousands of poor, low-skilled Hispanic newcomers from other countries, providing them jobs, education, healthcare and other services over the past 20 years, Virginia suddenly is guilty of systemic inequities. Hispanic immigrants didnt metamorphose from impoverished villagers overnight into prosperous middle-class Americans who can work safely at home on their computers, so we are stained by inequity!

How have we supposedly failed our Hispanic citizens and residents? Foy suggests that Latinos have inadequate access to testing. What evidence does she have that Latinos are any less likely to be tested than blacks, whites, or Asians? She presents none in the letter. But consider this: 43% of all Virginians found to carry the COVID-19 virus(whose race is known) are Hispanics. How do we come by this statistics? Its because they were tested! Someone, somewhere, somehow, tested them.

If Latinos consistently tested positive for the virus at higher rates than other groups say, that 20% of Hispanics tested positive, while for other groups only 10% tested positive it might suggest that only the sickest Hispanic patients with the most visible symptoms were being tested, and that Hispanics generally were being under-tested. But the Virginia Department of Health doesnt break out data on the number of tests administered by race/ethnicity, so we cant tell. Perhaps VDH has that data, but it does not publish it on its COVID-19 dashboard. Of one thing we can be reasonably certain, Foy has not crunched those numbers. If she had, she would have cited them. Basically, shes just making stuff up.

Now, lets talk about access to the health care system. Hispanics account for 35% of all hospitalizations in the state. Despite Virginias systemic inequities, somewhere, somehow, 2,277 Hispanic COVID-19 patients so far have managed to find hospitals to take care of them. One possible retort is that 35% of all hospitalizations is lower than 43% of all confirmed cases, therefore, some Latinos might have been denied access to hospitals. That discrepancy is easily explained: The Hispanic population skews younger that than of other racial/ethnic groups. Because they are younger on average, fewer experience symptoms severe enough to require hospitalization.

Well, surely Hispanics are getting second-class treatment when they wind up in the hospital. Not so. While accounting for 35% of all hospitalizations in Virginia, Hispanics account for only 11.4% of deaths. That suggests to me that the health care provided Latinos is pretty darn good, and that any insinuation otherwise is a slur and a slander on Virginia doctors, nurses, hospital administrators and other providers.

Bacons bottom line: There is no statistical evidence in the public domain that Virginia Hispanics are tested less for COVID-19, that Hispanics infected by the virus enjoy less access to hospitals, or that Hispanic patients receive inferior treatment in any way. Perhaps such evidence does exist. But Foy doesnt cite it. It is reckless and irresponsible to spout off about inequities, systemic factors and disparate access without any supporting proof. Of course, she is hardly the only one to make such claims I single her out only because her letter has been widely quoted in the media. But repeating an unsubstantiated claim over and over and over does not make it true.

Related

Visit link:
Are Hispanics Victims of Inequities in COVID-19 Epidemic? - Bacon's Rebellion

Read More...

Spanish antibody study shows 5% of population exposed to coronavirus – ETHealthworld.com

Thursday, July 9th, 2020

Representative Image (Reuters)MADRID - Results from the final stage of a nationwide antibody study show some 5.2% of Spain's population has been exposed to the new coronavirus, health officials said on Monday, confirming findings from earlier stages.

The study, which tested nearly 70,000 people across Spain three times over the past three months, found the virus' prevalence had not altered significantly since preliminary results were published in May.

It also suggested that immunity to the virus can be short-lived, with 14% of participants who tested positive for antibodies in the first stage subsequently testing negative in the last stage.

"Immunity can be incomplete, it can be transitory, it can last for just a short time and then disappear," said Dr Raquel Yotti, director of Spain's Carlos III Health Institute, which co-led the study.

The loss of immunity was most common among people who never developed symptoms.

Speaking at a news conference, she appealed to Spaniards to remain prudent, particularly those who had recovered from the virus and considered themselves immune.

"We can't relax, we must keep protecting ourselves and protecting others," she said.

Hit by one of the world's most severe outbreaks, Spain confined its population to their homes in mid-March, gradually lifting restrictions from May as the death rate fell.

International borders were opened at the beginning of July, providing a shot in the arm to the country's struggling tourism sector.

But in a sign that the risk is far from over, the regions of Galicia and Catalonia imposed local lockdowns over the weekend, isolating some 270,000 people after small-scale outbreaks were detected.

Catalonia - which was in 2019 the most visited Spanish region by foreign tourists - sought on Monday to reassure visitors, saying the lockdown in the Segria county only affected 2.5% of the region's population.

"Catalonia remains open and with all guarantees," said regional foreign affairs top official Bernat Sole at a news briefing. "Tourists and the commercial and economic sector can enter and leave Catalonia in the same conditions (as before)".

(Reporting by Nathan Allen, Inti Landauro and Joan Faus; Editing by Andrei Khalip and Alex Richardson)

Read the original post:
Spanish antibody study shows 5% of population exposed to coronavirus - ETHealthworld.com

Read More...

Infection Control in Cancer Therapy Market (impact of COVID-19) Growth, Overview with Detailed Analysis 2020-2026| Kimberly Clark Corporation, 3M…

Thursday, July 9th, 2020

COVID-19 Impact on GlobalInfection Control in Cancer TherapyMarket Size, Status and Forecast 2020-2026

This report studies theInfection Control in Cancer Therapy marketwith many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the completeInfection Control in Cancer Therapy marketanalysis segmented by companies, region, type and applications in the report.

New vendors in the market are facing tough competition from established international vendors as they struggle with technological innovations, reliability and quality issues. The report will answer questions about the current market developments and the scope of competition, opportunity cost and more.

The major players covered in Infection Control in Cancer Therapy Market:Kimberly Clark Corporation, 3M Healthcare Company, Honeywell International, Inc., Getinge Group AB, Sterigenics International, Sakura Global Holding Company, Arizant Healthcare Inc., Nordion, Cisa S.P.A., Steris Corporation, Nordion, Inc., Ahlstrom Filtration LLC, Membrana GmbH, Synergy Health, Plc, Advanced Sterilization Products Services, Inc

The final report will add the analysis of the Impact of Covid-19 in this report Infection Control in Cancer Therapy industry.

Get a Sample Copy @https://www.reportsandmarkets.com/sample-request/covid-19-impact-on-global-infection-control-in-cancer-therapy-market-size-status-and-forecast-2020-2026

Infection Control in Cancer TherapyMarket in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting. An Infection Control in Cancer Therapy Market provides an extensive view of size; trends and shape have been developed in this report to identify factors that will exhibit a significant impact in boosting the sales of Infection Control in Cancer Therapy Market in the near future.

This report focuses on the globalInfection Control in Cancer Therapystatus, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infection Control in Cancer Therapy development inUnited States, Europe, China, Japan, Southeast Asia, India, and Central & South America.

Market segment by Type, the product can be split into

Market segment by Application, split into

TheInfection Control in Cancer Therapymarket is a comprehensive report which offers a meticulous overview of the market share, size, trends, demand, product analysis, application analysis, regional outlook, competitive strategies, forecasts, and strategies impacting the Infection Control in Cancer Therapy Industry. The report includes a detailed analysis of the market competitive landscape, with the help of detailed business profiles, SWOT analysis, project feasibility analysis, and several other details about the key companies operating in the market.

The study objectives of this report are:

Inquire More about This Report @https://www.reportsandmarkets.com/enquiry/covid-19-impact-on-global-infection-control-in-cancer-therapy-market-size-status-and-forecast-2020-2026

TheInfection Control in Cancer Therapymarket research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

Key questions answered in this report

Table of Contents

Chapter 1:GlobalInfection Control in Cancer TherapyMarket Overview

Chapter 2:Infection Control in Cancer Therapy Market Data Analysis

Chapter 3:Infection Control in Cancer Therapy Technical Data Analysis

Chapter 4:Infection Control in Cancer Therapy Government Policy and News

Chapter 5:Global Infection Control in Cancer Therapy Market Manufacturing Process and Cost Structure

Chapter 6:Infection Control in Cancer Therapy Productions Supply Sales Demand Market Status and Forecast

Chapter 7:Infection Control in Cancer Therapy Key Manufacturers

Chapter 8:Up and Down Stream Industry Analysis

Chapter 9:Marketing Strategy -Infection Control in Cancer Therapy Analysis

Chapter 10:Infection Control in Cancer Therapy Development Trend Analysis

Chapter 11:Global Infection Control in Cancer Therapy Market New Project Investment Feasibility Analysis

About Us:

Reports and Marketsis not just another company in this domain but is a part of a veteran group calledAlgoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Read more from the original source:
Infection Control in Cancer Therapy Market (impact of COVID-19) Growth, Overview with Detailed Analysis 2020-2026| Kimberly Clark Corporation, 3M...

Read More...

Detector Switches Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

Tuesday, July 7th, 2020

New Jersey, United States,- Market Research Intellect sheds light on the market scope, potential, and performance perspective of the Global Detector Switches Market by carrying out an extensive market analysis. Pivotal market aspects like market trends, the shift in customer preferences, fluctuating consumption, cost volatility, the product range available in the market, growth rate, drivers and constraints, financial standing, and challenges existing in the market are comprehensively evaluated to deduce their impact on the growth of the market in the coming years. The report also gives an industry-wide competitive analysis, highlighting the different market segments, individual market share of leading players, and the contemporary market scenario and the most vital elements to study while assessing the global Detector Switches market.

The research study includes the latest updates about the COVID-19 impact on the Detector Switches sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Leading Detector Switches manufacturers/companies operating at both regional and global levels:

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=272022&utm_source=3WN&utm_medium=888

The Detector Switches market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Detector Switches market.

This study analyzes the growth of Detector Switches based on the present, past and futuristic data and will render complete information about the Detector Switches industry to the market-leading industry players that will guide the direction of the Detector Switches market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Detector Switches market. Additionally, it includes a share of each segment of the Detector Switches market, giving methodical information about types and applications of the market.

Reasons for Buying Detector Switches Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Detector Switches market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=272022&utm_source=3WN&utm_medium=888

In the end, the Detector Switches market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the global Detector Switches market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Solid State LiDAR sensor Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Solubility Enhancement Excipients Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Sound Barrier Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Soy Beverage Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Soy Desserts Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Go here to read the rest:
Detector Switches Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News

Read More...

Global Plasma Therapy Market: Industry Size, Growth, Analysis And Forecast of 2023 – 3rd Watch News

Tuesday, July 7th, 2020

Global Plasma Therapy Industry

New Study on 2018-2023 Plasma Therapy Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast added to Wise Guy Reports Database

The market for plasma therapy across the globe is expected to propel significantly during the forecast period. The global plasma therapy market is expected to grow impressively with a CAGR of 13.1% during 2018-2023. The factors driving the plasma therapy market are rising prevalence of life threatening diseases which includes various neurological system disorders such as chronic inflammatory demyelinating polyneuropathy (CIPD), idiopathic thrombocytopenic purpura (ITP), multifocal motor neuropathy (MMN). In addition, the rise in the occurrence of contagious diseases such as hepatitis A&B, tetanus and rabies is estimated to impact the market positively during the forecast period.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3204468-global-plasma-therapy-market-research-and-forecast-2018-2023

With an impressive technological advancement over the period has added much more to the therapies for treatment of various diseases which has also led to introduction of cost effective protein fractioning technologies from plasma. This is also being seen as a major booster to the growth within the plasma therapy market during the forecast period. As per estimates by WHO about 108 million global blood donations come from the high-income countries, which is the home for 18% of the worlds population. Presence of favourable government initiates for the development of plasma derived medicine and rising awareness regarding the importance of blood donation are the key drivers for this market.

On the geographical forefront, North America is a leader held the market share in 2017 which is expected to sustain during the forecast period as well. This is mainly due to the growing number of hospitals and clinics which is increasing the demand for the plasma derived from proteins. They key driving forces expected to boost the market of plasma therapy in North America are rising awareness levels among the blood donors, presence of advanced protein fractioning procedures, and higher per capita income in the developed countries. Furthermore, APAC region is also considered to be fastest growing region mainly due to growing medical tourism, technological advancement, rising disposable income of the patients, rising healthcare practitioners awareness, and increasing government initiatives pertaining to the development of plasma protein medicines are expected to fuel the demand of plasma protein product. The report includes detailed market overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, strategic recommendations, key company analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.

Key players of plasma therapy market include CSL limited, Telecris, Baxter, Grifols, Octapharma, Kedrion, and Chengdu Inst, Japan Red Cross, LFB group (France), Shanghai Blood Institute, BPL group (UK), and Sanquin.

RESEARCH METHODOLOGY

The market study of plasma therapy market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:

Financial reports of companies involved in the marketAuthentic Public DatabasesWhitepapers, research-papers and news blogsCompany websites and their product catalogue.Supplier Websites such as Alibaba, amazon for pricing analysis.The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

The Report Covers:

Comprehensive research methodology of global plasma therapy marketIn-depth analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global plasma therapy marketInsights about market determinants which are stimulating the global plasma therapy marketDetailed and extensive market segments with regional distribution of forecasted revenuesExtensive profiles and recent developments of market players

Some points from table of content:

REPORT SUMMARY1.1. RESEARCH METHODS AND TOOLS1.2. MARKET BREAKDOWN1.2.1. BY SEGMENTS1.2.2. BY GEOGRAPHY1.2.3. VALUE CHAIN2 MARKET OVERVIEW AND INSIGHTS2.1. DEFINITION2.2. PRICING ANALYSIS2.3. ANALYST INSIGHT & CURRENT MARKET TRENDS2.3.1. KEY FINDINGS2.3.2. RECOMMENDATION2.3.3. CONCLUSION2.4. REGULATION2.4.1. REGULATIONS RELATED TO BLOOD AND BLOOD COMPONENTS2.4.2. REGULATIONS ON CLINICAL TRIALS2.4.2.1. UNITED STATES2.4.2.2. EUROPEAN UNION2.4.2.3. CHINA2.4.2.4. INDIA2.4.3. DRUG AND DEVICE REGULATIONS2.4.3.1. UNITED STATES2.4.3.2. EUROPEAN UNION2.4.3.3. CHINA2.4.3.4. INDIA2.4.3.5. JAPAN2.5. PATENT ANALYSIS

Also Read: https://www.openpr.com/news/1075237/global-plasma-therapy-market-industry-size-growth-analysis-and-forecast-of-2023.html

3 MARKET DETERMINANT3.1. MOTIVATORS3.1.1. GROWING NUMBER OF NEUROLOGICAL PATIENTS GLOBALLY3.1.2. RISING DISPOSABLE INCOME IN THE DEVELOPING COUNTRIES3.1.3. RISING CASES OF ARTHIRITIS GLOBALLY3.1.4. RISING HEALTHCARE EXPENDITURE AND R&D IN STEM CELL PRP FOR CANCER TREATMENT3.1.5. RISE IN PERSONALIZED HEALTHCARE3.2. RESTRAINTS3.2.1. HIGH COST OF PLASMA THERAPY3.2.2. LACK OF REIMBURSEMENT POLICIES3.3. OPPORTUNITIES3.3.1. RISING CASES ORTHOPAEDIC AND NEUROLOGICAL CASES3.3.2. GROWING APPLICATION IN VARIOUS FIELDS3.3.3. GROWING MEDICAL TOURISM IN EMERGING COUNTRIES3.3.4. RISING ADOPTION OF PRP IN SPORTS INJURIES3.3.5. CHALLENGES3.3.6. DEVELOPMENTS IN OTHER FIELDS OF REGENERATIVE MEDICINE3.3.7. RESTRICTED USE OF PRP FOR DIABETIC AND KIDNEY PATIENTS4 MARKET SEGMENTATION4.1. PLASMA THERAPY BY SOURCE4.1.1. AUTOLOGOUS4.1.2. ALLOGENIC4.2. PLASMA THERAPY BY APPLICATION4.2.1. ORTHOPAEDICS4.2.1.1. ARTHIRITIS4.2.1.2. BONE REPAIR AND REGENERATION4.2.1.3. CHRONIC TENDINITIS4.2.2. CARDIAC MUSCLE INJURY4.2.3. DERMATOLOGY4.2.3.1. ANDROGENIC ALOPECIA4.2.3.2. PLASTIC SURGERY4.2.4. DENTAL4.2.5. NERVE INJURY4.2.6. OTHER APPLICATIONS4.3. PLASMA THERAPY BY TYPE4.3.1. LEUKOCYTE-RICH FIBRIN4.3.2. PURE PLATELET-RICH FIBRIN4.3.3. LEUKOCYTE-RICH PRP4.3.4. PURE PRP4.4. PLASMA THERAPY BY END USERS4.4.1. HOSPITALS AND CLINICS4.4.2. RESEARCH INSTITUTES4.4.3. OTHERS5 COMPETITIVE LANDSCAPE5.1. KEY COMPANY ANALYSIS5.2. KEY STRATEGIES6 REGIONAL ANALYSIS6.1. NORTH AMERICA6.1.1. UNITED STATES6.1.2. CANADA6.2. EUROPE6.2.1. UNITED KINGDOM6.2.2. FRANCE6.2.3. GERMANY6.2.4. ITALY6.2.5. SPAIN6.2.6. REST OF THE EUROPE6.3. ASIA PACIFIC6.3.1. INDIA6.3.2. CHINA6.3.3. JAPAN6.3.4. REST OF THE ASIA PACIFIC6.4. REST OF THE WORLD7 COMPANY PROFILES7.1. BAXTER INTERNATIONAL7.2. BIOLIFE PLASMA SERVICES7.3. BIOTEST7.4. BIO PRODUCT LABORATORY LTD. (BPL)7.5. CAMBRYN BIOLOGICS LLC

Continued.

or more information or any query mail at[emailprotected]

About UsWise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:Norah Trent+1 646 845 9349 / +44 208 133 9349Follow on LinkedIn:https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

View post:
Global Plasma Therapy Market: Industry Size, Growth, Analysis And Forecast of 2023 - 3rd Watch News

Read More...

Maui Detective Melvin R Johnson Arrested for OUI 4th of July – Maui Time

Tuesday, July 7th, 2020

Mr. Melvin R. Johnson Jr. was arrested for Operating a Vehicle Under the Influence of an Intoxicant

In a recent Maui Police Department press release: Mr. Melvin R. Johnson Jr. was arrested for Operating a Vehicle Under the Influence of an Intoxicant on 07/04/2020 at 7:59 pm. Mr. Johnson is a 25-year veteran with the Maui Police Department and currently assigned to the Wailuku Criminal Investigative Division. Johnson was off-duty at the time of his arrest. Details of the incident are still under investigation. He was released after posting $1,000.00 bail. MPD will also be conducting an internal investigation into this matter.

Chief Tivoli Faaumu would like the public to know that he holds his officers accountable for their actions, on and off duty. This is an on-going investigation and every person who is arrested, is entitled to Due Process.

July 4th, 2020- Impaired Driving Enforcement Campaign RESULTS:

In continuing with the Maui Police Departments ZERO TOLERANCE approach to Impaired Driving, Officers were out in force starting Thursday July 3 and continuing through the July 4th holiday weekend.

The Maui Police Department made (10) ten arrests Operating a Vehicle Under the Influence of an Intoxicant (OVUII), and (2) two arrests for Habitually Operating a Vehicle Under the Influence of an Intoxicant. Traffic Officers also towed (10) ten vehicles related to OVUII arrests. Any vehicle that was not towed under the new County ordinance had disabling damages due to a motor vehicle crash, or there was a sober passenger able to legally drive the vehicle.

In total, the Maui Police Department conducted (15) fifteen separate checkpoints countywide screening 1331 vehicles. There were ZERO alcohol/drug impaired driving fatalities over the July 4th holiday.

As of July 5, 2020 Maui County Police have made 262 Operating a Vehicle Under the Influence of an Intoxicant (OVUII) arrests with 13 Habitually Operating a Vehicle Under the Influence of an Intoxicant for a total of 275 total year to date arrests, compared to 280 the same time last year.

In the State of Hawaii, an OVUII arrest becomes a felony on the third arrest following two prior convictions within 10 years of the instant offense. Or if a person was convicted of Habitual OVUII one or more times within 10 years prior to the instant offense.

One notable arrest during this weekends enforcement effort was the arrest of 21 year old Wailuku resident Christian Kalalau Johnson. On July 4, 2020 at 12:20AM, Mr Kalalau Johnson was stopped at an Intoxication control checkpoint located at Haleakala Highway and Hana Highway. During the screening of Mr. Kalalau Johnson, he was found to have signs of impairment. Mr. Kalalau Johnson failed the field sobriety tests and was placed under arrest. In the course of arresting Mr. Kalalau Johnson he assaulted two officers causing minor injuries to both officers. Both officers received treatment for their injuries and were able to immediately return to work.

Mr. Kalalau Johnson was subsequently arrested and charged for Operating a Vehicle Under The influence of an Intoxicant (OVUII), Resisting Arrest, and (2 counts) of Assault Against A Police Officer. Mr. Kalalau Johnson bail was set at $3,200.

comments

View original post here:
Maui Detective Melvin R Johnson Arrested for OUI 4th of July - Maui Time

Read More...

Cell Separation Technology Market by Leading Manufacturers, Demand and Growth Overview 2019 to 2027 – Jewish Life News

Friday, July 3rd, 2020

Transparency Market Research (TMR) has published a new report on the globalcell separation technology marketfor the forecast period of 20192027. According to the report, the global cell separation technology market was valued at ~ US$ 5 Bn in 2018, and is projected to expand at a double-digit CAGR during the forecast period.

Planning To Lay Down Future Strategy? Request Brochure Of Cell Separation Technology Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1925

Cell separation, also known as cell sorting or cell isolation, is the process of removing cells from biological samples such as tissue or whole blood. Cell separation is a powerful technology that assists biological research. Rising incidences of chronic illnesses across the globe are likely to boost the development of regenerative medicines or tissue engineering, which further boosts the adoption of cell separation technologies by researchers.

Expansion of the global cell separation technology market is attributed to an increase in technological advancements and surge in investments in research & development, such asstem cellresearch and cancer research. The rising geriatric population is another factor boosting the need for cell separation technologies Moreover, the geriatric population, globally, is more prone to long-term neurological and other chronic illnesses, which, in turn, is driving research to develop treatment for chronic illnesses. Furthermore, increase in the awareness about innovative technologies, such as microfluidics, fluorescent-activated cells sorting, and magnetic activated cells sorting is expected to propel the global cell separation technology market.

To Obtain All-Inclusive Information On Forecast Analysis Of Cell Separation Technology Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1925

North America dominated the global cell separation technology market in 2018, and the trend is anticipated to continue during the forecast period. This is attributed to technological advancements in offering cell separation solutions, presence of key players, and increased initiatives by governments for advancing the cell separation process. However, insufficient funding for the development of cell separation technologies is likely to hamper the global cell separation technology market during the forecast period. Asia Pacific is expected to be a highly lucrative market for cell separation technology during the forecast period, owing to improving healthcare infrastructure along with rising investments in research & development in the region.

Rising Incidences of Chronic Diseases, Worldwide, Boosting the Demand for Cell Therapy

Incidences of chronic diseases such as diabetes, obesity, arthritis, cardiac diseases, and cancer are increasing due to sedentary lifestyles, aging population, and increased alcohol consumption and cigarette smoking. According to the World Health Organization (WHO), by 2020, the mortality rate from chronic diseases is expected to reach73%, and in developing counties,70%deaths are estimated to be caused by chronic diseases. Southeast Asia, Eastern Mediterranean, and Africa are expected to be greatly affected by chronic diseases. Thus, the increasing burden of chronic diseases around the world is fuelling the demand for cellular therapies to treat chronic diseases. This, in turn, is driving focus and investments on research to develop effective treatments. Thus, increase in cellular research activities is boosting the global cell separation technology market.

Increase in Geriatric Population Boosting the Demand for Surgeries

The geriatric population is likely to suffer from chronic diseases such as cancer and neurological disorders more than the younger population. Moreover, the geriatric population is increasing at a rapid pace as compared to that of the younger population. Increase in the geriatric population aged above 65 years is projected to drive the incidences of Alzheimers, dementia, cancer, and immune diseases, which, in turn, is anticipated to boost the need for corrective treatment of these disorders. This is estimated to further drive the demand for clinical trials and research that require cell separation products. These factors are likely to boost the global cell separation technology market.

According to the United Nations, the geriatric population aged above 60 is expected to double by 2050 and triple by 2100, an increase from962 millionin 2017 to2.1 billionin 2050 and3.1 billionby 2100.

Productive Partnerships in Microfluidics Likely to Boost the Cell Separation Technology Market

Technological advancements are prompting companies to innovate in microfluidics cell separation technology. Strategic partnerships and collaborations is an ongoing trend, which is boosting the innovation and development of microfluidics-based products. Governments and stakeholders look upon the potential in single cell separation technology and its analysis, which drives them to invest in the development ofmicrofluidics. Companies are striving to build a platform by utilizing their expertise and experience to further offer enhanced solutions to end users.

Request For Covid19 Impact Analysis

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1925

Stem Cell Research to Account for a Prominent Share

Stem cell is a prominent cell therapy utilized in the development of regenerative medicine, which is employed in the replacement of tissues or organs, rather than treating them. Thus, stem cell accounted for a prominent share of the global market. The geriatric population is likely to increase at a rapid pace as compared to the adult population, by 2030, which is likely to attract the use of stem cell therapy for treatment. Stem cells require considerably higher number of clinical trials, which is likely to drive the demand for cell separation technology, globally. Rising stem cell research is likely to attract government and private funding, which, in turn, is estimated to offer significant opportunity for stem cell therapies.

Biotechnology & Pharmaceuticals Companies to Dominate the Market

The number of biotechnology companies operating across the globe is rising, especially in developing countries. Pharmaceutical companies are likely to use cells separation techniques to develop drugs and continue contributing through innovation. Growing research in stem cell has prompted companies to own large separate units to boost the same. Thus, advancements in developing drugs and treatments, such as CAR-T through cell separation technologies, are likely to drive the segment.

As per research, 449 public biotech companies operate in the U.S., which is expected to boost the biotechnology & pharmaceutical companies segment. In developing countries such as China, China Food and Drug Administration (CFDA) reforms pave the way for innovation to further boost biotechnology & pharmaceutical companies in the country.

Global Cell Separation Technology Market: Prominent Regions

North America to Dominate Global Market, While Asia Pacific to Offer Significant Opportunity

In terms of region, the global cell separation technology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global market in 2018, followed by Europe. North America accounted for a major share of the global cell separation technology market in 2018, owing to the development of cell separation advanced technologies, well-defined regulatory framework, and initiatives by governments in the region to further encourage the research industry. The U.S. is a major investor in stem cell research, which accelerates the development of regenerative medicines for the treatment of various long-term illnesses.

The cell separation technology market in Asia Pacific is projected to expand at a high CAGR from 2019 to 2027. This can be attributed to an increase in healthcare expenditure and large patient population, especially in countries such as India and China. Rising medical tourism in the region and technological advancements are likely to drive the cell separation technology market in the region.

Launching Innovative Products, and Acquisitions & Collaborations by Key Players Driving Global Cell Separation Technology Market

The global cell separation technology market is highly competitive in terms of number of players. Key players operating in the global cell separation technology market include Akadeum Life Sciences, STEMCELL Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Miltenyi Biotech, 10X Genomics, Thermo Fisher Scientific, Inc., Zeiss, GE Healthcare Life Sciences, PerkinElmer, Inc., and QIAGEN.

These players have adopted various strategies such as expanding their product portfolios by launching new cell separation kits and devices, and participation in acquisitions, establishing strong distribution networks. Companies are expanding their geographic presence in order sustain in the global cell separation technology market. For instance, in May 2019, Akadeum Life Sciences launched seven new microbubble-based products at a conference. In July 2017, BD received the U.S. FDAs clearance for its BD FACS Lyric flow cytometer system, which is used in the diagnosis of immunological disorders.

Visit link:
Cell Separation Technology Market by Leading Manufacturers, Demand and Growth Overview 2019 to 2027 - Jewish Life News

Read More...

Spinal Cord Trauma Treatment Market Size : Technological Advancement and Growth Analysis with Forecast to 2025 – 3rd Watch News

Monday, June 29th, 2020

New York City, United States The effect of the coronavirus pandemic and the lockdown it activated is unmistakably obvious in budgetary markets. Yet, there is still no clearness on the more profound effect that it is having across organizations and modern areas. In view of evaluations made by various examiners and industry body Ficci, here is an effect investigation in human services area.

Spinal Cord Trauma Treatment Market: Global Industry Analysis 2012 2016 and Forecast 2017 2025is the recent report of Persistence Market Research that throws light on the overall market scenario during the period of eight years, i.e. 2017-2025. According to this report, Globalspinal cord trauma treatment marketis expected to witness significant growth during the forecast period.

This growth is expected to be primarily driven by increasing incidence of spinal cord trauma, and increasing government support to reduce the burden of spinal cord injuries. Additionally, development of nerve cells growth therapy is expected to boost the market in near future.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/17353

Company Profiles

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/17353

The global market for spinal cord trauma treatment is is estimated to be valued at US$ 2,276.3 Mn in terms of value by the end of 2017. The global spinal cord trauma treatment market is expected to expand at a CAGR of 3.7% over the forecast period to reach a value of US$ 3,036.2 Mn by 2025end.

Global Spinal Cord Trauma Treatment Market: Trends

Global Spinal Cord Trauma Treatment Market: Forecast by End User

On the basis of end user, the global spinal cord trauma treatment market is segmented into hospitals and trauma centers. Hospitals segment dominated the global spinal cord trauma treatment market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period.

Hospitals and trauma centers segments are expected to approximately similar attractive index. Hospitals segment accounted for 53.2% value share in 2017 and is projected to account for 52.5% share by 2025 end.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/17353

Global Spinal Cord Trauma Treatment Market: Forecast by Injury Type

On the basis of injury type, the global spinal cord trauma treatment market is segmented into complete spinal cord injuries and partial spinal cord injuries.

Partial spinal cord trauma treatment segment is expected to show better growth than the completed spinal cord treatment segment due to higher growth in the incidence rate of partial spinal cord trauma than the complete spinal cord trauma. With US$ 1,870.3 Mn market value in 2025, this segment is likely to expand at CAGR 3.8% throughout the projected period.

Global Spinal Cord Trauma Treatment Market: Forecast by Treatment Type

On the basis of treatment type, the global spinal cord trauma treatment market is segmented into corticosteroid, surgery, and spinal traction segments.

Surgery segment dominated the global spinal cord trauma treatment market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. Surgery segment is the most attractive segment, with attractiveness index of 2.6 over the forecast period.

Global Spinal Cord Trauma Treatment Market: Forecast by Region

This market is segmented into five regions such as North America, Latin America, Europe, APAC and MEA. Asia-Pacific account for the largest market share in the global spinal cord trauma treatment market.

Large patient population due to the high rate of road accidents and crime is making the Asia Pacific region most attractive market for spinal cord trauma treatment. On the other hand, MEA and Latin America is expected to be the least attractive market for spinal cord trauma treatment, with attractiveness index of 0.3 and 0.5 respectively over the forecast period.

Report Highlights:

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Feminine Hygiene Product Market Feminine Hygiene Products Market Segmented By Sanitary Pads/Napkins, Tampons, Panty Liners, Menstrual Cups, and Feminine Hygiene Wash.For More Information

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

Excerpt from:
Spinal Cord Trauma Treatment Market Size : Technological Advancement and Growth Analysis with Forecast to 2025 - 3rd Watch News

Read More...

Page 21234..10..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick